Meaning
Genotoxicity testing protocols screen chemical substances for their ability to induce chromosomal damage or numerical abnormalities in cultured mammalian cells. An in vitro micronucleus assay identifies both clastogenic and aneugenic events by measuring the formation of small, membrane-bound nuclear fragments.
Genotoxic Endpoint
Treated cells undergo division, and those with damaged chromosomes or spindle apparatus defects fail to incorporate whole chromosomes or fragments into the main daughter nuclei. By quantifying these cellular structures, the in vitro micronucleus assay provides a rapid assessment of structural and numerical chromosomal damage caused by polymer leachables.
Cellular Response
The assay utilizes human or rodent cell lines that are exposed to varying concentrations of the test substance. Under the protocol, the in vitro micronucleus assay measures cell viability alongside micronucleus frequency to ensure that cytotoxicity does not produce false-positive results.
Compliance Role
Regulatory bodies mandate this chromosome-level test as part of the safety evaluation for materials used in medical devices and food contact applications. When assessing a new plastic additive, a negative result in the in vitro micronucleus assay reduces the need for expensive in vivo animal testing. This testing strategy accelerates the approval process for high-performance resins in sensitive healthcare markets while ensuring rigorous patient safety.